BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho SY, Szabo Z. Molecular imaging of urogenital diseases. Semin Nucl Med 2014;44:93-109. [PMID: 24484747 DOI: 10.1053/j.semnuclmed.2013.10.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Freeman LM, Donald Blaufox M. Seminars in nuclear medicine. Semin Nucl Med 2014;44:77-8. [PMID: 24484744 DOI: 10.1053/j.semnuclmed.2013.11.001] [Reference Citation Analysis]
2 Tosoian JJ, Gorin MA, Ross AE, Pienta KJ, Tran PT, Schaeffer EM. Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations. Nat Rev Urol. 2017;14:15-25. [PMID: 27725639 DOI: 10.1038/nrurol.2016.175] [Cited by in Crossref: 121] [Cited by in F6Publishing: 124] [Article Influence: 20.2] [Reference Citation Analysis]
3 Joice GA, Rowe SP, Pienta KJ, Gorin MA. Oligometastatic prostate cancer: shaping the definition with molecular imaging and an improved understanding of tumor biology. Current Opinion in Urology 2017;27:533-41. [DOI: 10.1097/mou.0000000000000449] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
4 Pathuri G, Hedrick AF, Awasthi V, Cowley BD, Gali H. Evaluation of [ 18 F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease. Nuclear Medicine and Biology 2016;43:1-5. [DOI: 10.1016/j.nucmedbio.2015.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Bouchelouche K, Turkbey B, Choyke PL. PSMA PET and Radionuclide Therapy in Prostate Cancer. Semin Nucl Med 2016;46:522-35. [PMID: 27825432 DOI: 10.1053/j.semnuclmed.2016.07.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 10.3] [Reference Citation Analysis]
6 Evangelista L, Cervino AR, Guttilla A, Zattoni F, Cuccurullo V, Mansi L. ¹⁸F-fluoromethylcholine or ¹⁸F-fluoroethylcholine pet for prostate cancer imaging: which is better? A literature revision. Nucl Med Biol 2015;42:340-8. [PMID: 25618796 DOI: 10.1016/j.nucmedbio.2014.12.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
7 Koo KC, Dasgupta P. Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review. Yonsei Med J 2018;59:567-79. [PMID: 29869454 DOI: 10.3349/ymj.2018.59.5.567] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
8 Liolios C, Sachpekidis C, Schäfer M, Kopka K. Bispecific radioligands targeting prostate-specific membrane antigen and gastrin-releasing peptide receptors on the surface of prostate cancer cells. J Label Compd Radiopharm 2019;62:510-22. [DOI: 10.1002/jlcr.3749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mafeld S, Vasdev N, Patel A, Ali T, Lane T, Boustead G, Thorpe AC, Adshead JM, Haslam P. Evolving role of positron emission tomography (PET) in urological malignancy. BJU Int 2015;116:538-45. [PMID: 25410715 DOI: 10.1111/bju.12988] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Bouchelouche K, Turkbey B, Choyke PL. Advances in imaging modalities in prostate cancer. Curr Opin Oncol 2015;27:224-31. [PMID: 25715326 DOI: 10.1097/CCO.0000000000000174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tantawy MN, Charles Manning H, Peterson TE, Colvin DC, Gore JC, Lu W, Chen Z, Chad Quarles C. Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model. Mol Imaging Biol 2018;20:200-4. [PMID: 28822038 DOI: 10.1007/s11307-017-1113-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Cuccurullo V, Di Stasio GD, Mansi L. Nuclear Medicine in Prostate Cancer: A New Era for Radiotracers. World J Nucl Med 2018;17:70-8. [PMID: 29719480 DOI: 10.4103/wjnm.WJNM_54_17] [Cited by in F6Publishing: 4] [Reference Citation Analysis]